Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: An inception cohort study with a nested case-control analysis

British Journal of Dermatology

Volumn 160, Issue 5, 2009, Pages 1048-1056

  Brauchli, Y B ^a   Jick, S S ^b   Miret, M ^c   Meier, C R ^a,b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Serono International SA   (Switzerland)

Author keywords

Incidence rates; Myocardial infarction; Psoriasis; Stroke; Transient ischaemic attack

Indexed keywords

ANTIPSORIASIS AGENT; AZATHIOPRINE; CALCIPOTRIOL; CARBAMIC ACID DERIVATIVE; COAL TAR; CORTICOSTEROID; CYCLOSPORIN A; DITHRANOL; EMOLLIENT AGENT; ETRETIN; HYDROXYCARBAMATE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN; SALICYLIC ACID; TAZAROTENE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HEART INFARCTION; HUMAN; INCIDENCE; INFANT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHOTOTHERAPY; POPULATION RESEARCH; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; RISK FACTOR; SCHOOL CHILD; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; PSORIASIS; RISK ASSESSMENT; STROKE; TIME FACTORS; YOUNG ADULT;

EID: 64849085648     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.09020.x     Document Type: Article

References (50)

1. Gelfand JM, Weinstein R, Porter SB et al. Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005 141 : 1537 41.
2. Sabat R, Philipp S, Höflich C et al. Immunopathogenesis of psoriasis. Exp Dermatol 2007 16 : 779 98.
3. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. The inflammatory response in mild and in severe psoriasis. Br J Dermatol 2004 150 : 917 28.
4. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006 6 : 508 19.
5. Shapiro J, Cohen AD, David M et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007 56 : 629 34.
6. Ludwig RJ, Herzog C, Rostock A et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007 156 : 271 6.
7. Kimhi O, Caspi D, Bornstein NM et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum 2007 36 : 203 9.
8. del Rincon ID, Williams K, Stern MP et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001 44 : 2737 45.
9. Fischer LM, Schlienger RG, Matter C et al. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol 2004 93 : 198 200.
10. Naldi L, Peli L, Parazzini F. Association of early-stage psoriasis with smoking and male alcohol consumption: evidence from an Italian case-control study. Arch Dermatol 1999 135 : 1479 84.
11. Naldi L, Chatenoud L, Linder D et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study. J Invest Dermatol 2005 125 : 61 7.
12. Gisondi P, Tessari G, Conti A et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007 157 : 68 73.
13. Rocha-Pereira P, Santos-Silva A, Rebelo I et al. Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 2001 303 : 33 9.
14. Uyanik BS, Ari Z, Onur E et al. Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med 2002 40 : 65 8.
15. Mallbris L, Granath F, Hamsten A, Stahle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006 54 : 614 21.
16. Ena P, Madeddu P, Glorioso N et al. High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol 1985 40 : 199 205.
17. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995 32 : 982 6.
18. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004 19 : 225 30.
19. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986 172 : 298 304.
20. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988 91 : 197 201.
21. Neimann AL, Shin DB, Wang X et al. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 35.
22. Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008 159 : 895 902.
23. Gelfand JM, Neimann AL, Shin DB et al. Risk of myocardial infarction in patients with psoriasis. JAMA 2006 296 : 1735 41.
24. Gelfand JM, Azfar RS, Shin DB et al. Incidence of stroke in patients with psoriasis: a population-based study. J Invest Dermatol 2008 128 : S81 (Abstract).
25. Gelfand JM, Shin DB, Azfar RS et al. Prevalence of atherosclerotic diseases in patients with psoriasis: a population-based study using the General Practice Research Database. J Invest Dermatol 2008 128 : S81 (Abstract).
26. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997 350 : 1097 9.
27. Jick H. A database worth saving. Lancet 1997 350 : 1045 6.
28. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991 302 : 766 8.
29. Jick SS, Kaye JA, Vasilakis-Scaramozza C et al. Validity of the General Practice Research Database. Pharmacotherapy 2003 23 : 686 9.
30. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992 1 : 347 9.
31. Brauchli YB, Jick SS, Curtin F, Meier CR. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: a population based case-control study. J Am Acad Dermatol 2008 58 : 421 9.
32. Brauchli YB, Jick SS, Curtin F, Meier CR. Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study. Br J Dermatol 2008 158 : 1299 307.
33. Whooley MA. Depression and cardiovascular disease: healing the broken-hearted. JAMA 2006 295 : 2874 81.
34. Salaycik KA, Kelly-Hayes M, Beiser A et al. Depressive symptoms and risk of stroke: the Framingham study. Stroke 2007 38 : 16 21.
35. Fortune DG, Richards HL, Griffiths CE. Psychologic factors in psoriasis: consequences, mechanisms, and interventions. Dermatol Clin 2005 23 : 681 94.
36. Meier CR, Jick SS, Derby LE et al. Acute respiratory-tract infections and risk of first-time myocardial infarction. Lancet 1998 351 : 1467 71.
37. Varas-Lorenzo C, Rodriguez LA, Maguire A et al. Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis 2007 192 : 376 83.
38. Fry L, Baker BS. Triggering psoriasis: the role of infections and medications. Clin Dermatol 2007 25 : 606 15.
39. Abel EA, DiCicco LM, Orenberg EK et al. Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986 15 : 1007 22.
40. Haag MD, Bos MJ, Hofman A et al. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke. Arch Intern Med 2008 168 : 1219 24.
41. Iso H, Baba S, Mannami T et al. Alcohol consumption and risk of stroke among middle-aged men: the JPHC Study Cohort I. Stroke 2004 35 : 1124 9.
42. Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004 363 : 1184 6.
43. Rothwell PM, Coull AJ, Silver LE et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005 366 : 1773 83.
44. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978 99 : 469 75.
45. Choi HK, Hernan MA, Seeger JD et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 2002 359 : 1173 7.
46. Prodanovich S, Ma F, Taylor JR et al. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005 52 : 262 7.
47. van Halm VP, Nurmohamed MT, Twisk JW et al. Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther 2006 8 : R151.
48. Gibbs RG, Newson R, Lawrenson R et al. Diagnosis and initial management of stroke and transient ischemic attack across UK health regions from 1992 to 1996: experience of a national primary care database. Stroke 2001 32 : 1085 90.
49. Gelfand JM, Wang X, Qing L et al. Epidemiology and treatment patterns of psoriasis in the General Practice Research Database (GPRD). Pharmacoepidemiol Drug Saf 2005 14 (Suppl. S23.
50. Gelfand JM, Berlin J, van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom. Arch Dermatol 2003 139 : 1425 9.